|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/00 |
| (11) | Patento numeris | 2134330 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08744091.3 |
| Europos patento paraiškos padavimo data | 2008-03-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-12-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/057557 |
| Data | 2008-03-19 |
| (87) | Numeris | WO 2008/116024 |
| Data | 2008-09-25 |
| (30) | Numeris | Data | Šalis |
| 895735 P | 2007-03-19 | US | |
| 908921 P | 2007-03-29 | US | |
| 12771 | 2007-12-10 | US | |
| 26092 | 2008-02-04 | US |
| (72) |
PETERS, Perry, US
FURLANO, David, US
BAHR, Daun, US
VAN KAMMEN, Daniel, US
BRANN, Mark, US
|
| (73) |
Acadia Pharmaceuticals Inc.,
3911 Sorrento Valley Blvd., San Diego, CA 92121-1402,
US
|
| (54) | COMBINATIONS OF 5-HT2A INVERSE AGONISTS AND ANTAGONISTS WITH ANTIPSYCHOTICS |
| COMBINATIONS OF 5-HT2A INVERSE AGONISTS AND ANTAGONISTS WITH ANTIPSYCHOTICS |